Health Condition 1: O- Medical and Surgical Health Condition 2: O- Medical and Surgical
Conditions
Interventions
Intervention1: Intranasal Midazolam Spray and Oral Midazolam: Intranasal Midazolam Spray(0.1mL or 0.5mg per spray , 0.2mg/kg) and Oral Midazolam (5mg per mL ampoule, 0.5mg/kg) each for a total duratio
Sponsors
Dr Reem Khatib
Eligibility
Inclusion criteria
Inclusion criteria: 1-5 years aged patients of either sex ASA I – II Patients posted for routine paediatric surgeries Hemodynamically stable patients with all routine investigations within normal limits. Patients whose parents or guardians give written informed consent and are willing their child to be a part of the study.
Exclusion criteria
Exclusion criteria: 6 years and above ASA grade 3 and above known allergy to study drugs nasal pathology
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the effectiveness of preoperative Oral Midazolam with Intranasal Midazolam for sedative premedication in paediatric patients.Timepoint: Five point sedation score followed by parental separation score will be assessed at the end of 20 minutes from administeration of the drug. | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the effectiveness of preoperative Oral Midazolam with Intranasal Midazolam for sedative premedication in paediatric patients.Timepoint: Acceptance to mask & response to venepuncture will be assessed after 20 minutes of drug administer in the operating room The Modified Alderte score shall be assessed for 30 minutes from extubation in the recovery room | — |
Countries
India
Contacts
Public ContactReem Khatib
Dr D Y Patil Medical College, Hospital and Research Centre
Outcome results
None listed